| 发明名称 |
IMMUNOGENIC POLYPEPTIDE COMPOSED OF HLA-B7 RESTRICTED TUMOR ANTIGEN-DERIVED OPTIMIZED CRYPTIC PEPTIDES, AND USES THEREOF |
| 摘要 |
<p>The invention pertains to an optimized chimeric polypeptide for use in HLA-337 cancer patients, which comprises four optimized peptides derived from cryptic tumor epitopes (CEA, TERT, MAGE and HER-2/neu) to enhance their immunogenicity.</p> |
| 申请公布号 |
WO2016012921(A2) |
申请公布日期 |
2016.01.28 |
| 申请号 |
WO2015IB55438 |
申请日期 |
2015.07.17 |
| 申请人 |
VAXON BIOTECH |
发明人 |
GALLOU, CATHERINE;MENEZ-JAMET, JEANNE |
| 分类号 |
A61K39/00 |
主分类号 |
A61K39/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
